These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 192441)

  • 1. 5-Flourouracil in hepatocellular carcinoma: report of twenty-one cases.
    Link JS; Bateman JR; Paroly WS; Durkin WJ; Peters RL
    Cancer; 1977 May; 39(5):1936-9. PubMed ID: 192441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral fluorouracil therapy of hepatoma.
    Kennedy PS; Lehane DE; Smith FE; Lane M
    Cancer; 1977 May; 39(5):1930-5. PubMed ID: 192440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-Fluorouracil and d,l-leucovorin calcium are active to treat unresectable hepatocellular carcinoma patients: preliminary results of a phase II study.
    Porta C; Moroni M; Nastasi G; Arcangeli G
    Oncology; 1995; 52(6):487-91. PubMed ID: 7478436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical evaluation of 1-hexylcarbamoyl-5-fluorouracil (HCFU) in hepatocellular carcinoma].
    Shiraishi K; Kubo Y; Majima Y; Sato K; Sakemi T; Sakai T; Hirai K; Ninomiya F; Abe M; Tanikawa K
    Gan To Kagaku Ryoho; 1984 Nov; 11(11):2348-55. PubMed ID: 6093712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral doxifluridine in advanced hepatocellular carcinoma: A phase II study.
    Lencioni M; Falcone A; Allegrini G; Pfanner E; Masi G; Brunetti I; Di Marsico R; Fontana E; Orlandini C; Stampino CG; Bartolozzi C; Conte PF
    Oncology; 2000 Sep; 59(3):204-9. PubMed ID: 11053987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II trial of sorafenib in combination with 5-fluorouracil infusion in advanced hepatocellular carcinoma.
    Petrini I; Lencioni M; Ricasoli M; Iannopollo M; Orlandini C; Oliveri F; Bartolozzi C; Ricci S
    Cancer Chemother Pharmacol; 2012 Mar; 69(3):773-80. PubMed ID: 22033636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination chemotherapy with 5-fluorouracil (NSC-19893), methotrexate (NSC-740), and prednisolone (NSC-9900) (FAP protocol) for hepatoma.
    Umsawasdi T; Chainuvati T; Hitannant S; Nilprabhassorn P; Viranuvatti V
    Cancer Chemother Rep; 1975; 59(6):1167-9. PubMed ID: 177190
    [No Abstract]   [Full Text] [Related]  

  • 8. Intrahepatic arterial infusion of combination of mitomycin-C and 5-fluorouracil in treatment of primary and metastatic liver carcinoma.
    Misra NC; Jaiswal MS; Singh RV; Das B
    Cancer; 1977 Apr; 39(4):1425-9. PubMed ID: 192431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of advanced breast carcinoma with 5-fluorouracil: a randomized comparison of two routes of delivery.
    Chlebowski RT; Pugh RP; Weiner JM; Bateman JR
    Cancer; 1981 Oct; 48(8):1711-4. PubMed ID: 7284972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic intra-arterial interferon alpha 2b-based immunotherapy combined with 5-fluorouracil (5-FU)-based systemic chemotherapy for patients with hepatocellular carcinoma (HCC) not responsive and/or not eligible for conventional treatments: a pilot study.
    Vitale FV; Romeo P; Vasta F; Panebianco V; Calì S; Rotondo S; Ferraù F; La Greca M
    Anticancer Res; 2007; 27(6B):4077-81. PubMed ID: 18225574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of liver cancer with oral administration of N-(2'-furanidyl)-5 fluorouracil (FT207) (author's transl)].
    Okazaki N; Hattori N; Ono T; Kanda Y; Koyama S
    Nihon Shokakibyo Gakkai Zasshi; 1974 Jun; 71(6):597-601. PubMed ID: 4373606
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of elderly patients with hepatocellular carcinomas with mitomycin C and 5-fluorouracil].
    Fujii M; Murakami N; Matsuka Y; Ejiri T; Asano K
    Gan To Kagaku Ryoho; 1982 Oct; 9(10):1797-800. PubMed ID: 6307175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors predicting response and survival in 149 patients with unresectable hepatocellular carcinoma treated by combination cisplatin, interferon-alpha, doxorubicin and 5-fluorouracil chemotherapy.
    Leung TW; Tang AM; Zee B; Yu SC; Lai PB; Lau WY; Johnson PJ
    Cancer; 2002 Jan; 94(2):421-7. PubMed ID: 11905412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase III study comparing the clinical utility of four regimens of 5-fluorouracil: a preliminary report.
    Ansfield F; Klotz J; Nealon T; Ramirez G; Minton J; Hill G; Wilson W; Davis H; Cornell G
    Cancer; 1977 Jan; 39(1):34-40. PubMed ID: 318916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hepatocellular carcinoma treated by continuous hepatic arterial infusion of etoposide, CDDP and 5-FU].
    Tarusawa K; Yodono H; Sasaki T; Ikami I; Fujii N; Akimura R; Nakamura Y; Kanehira J; Midorikawa H; Kimura T
    Gan To Kagaku Ryoho; 1990 Jan; 17(1):53-8. PubMed ID: 2153370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of recurrent hepatocellular carcinoma successfully treated with a combination therapy of interferon-alpha and intravenous continuous infusion of 5-fluorouracil].
    Katsuramaki T; Furuhata T; Kimura Y; Yamaguchi K; Ohmura T; Hata F; Mukaiya M; Hirata K
    Gan To Kagaku Ryoho; 2002 Oct; 29(10):1801-4. PubMed ID: 12402433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adriamycin and 5-fluorouracil in the treatment of advanced hepatoma: a Southwest Oncology Group study.
    Baker LH; Saiki JH; Jones SE; Hewlett JS; Brownlee RW; Stephens RL; Vaitkevicius VK
    Cancer Treat Rep; 1977 Nov; 61(8):1595-7. PubMed ID: 200359
    [No Abstract]   [Full Text] [Related]  

  • 18. Phase I and pharmacokinetic study of 5-fluorouracil administered by 5-day continuous infusion in patients with hepatocellular carcinoma.
    Ueno H; Okada S; Okusaka T; Ikeda M; Kuriyama H
    Cancer Chemother Pharmacol; 2002 Feb; 49(2):155-60. PubMed ID: 11862430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrahepatic chemotherapy for unresectable hepatocellular carcinoma.
    Doci R; Bignami P; Bozzetti F; Bonfanti G; Audisio R; Colombo M; Gennari L
    Cancer; 1988 May; 61(10):1983-7. PubMed ID: 2834036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II trial of systemic continuous fluorouracil and subcutaneous recombinant interferon Alfa-2b for treatment of hepatocellular carcinoma.
    Patt YZ; Hassan MM; Lozano RD; Brown TD; Vauthey JN; Curley SA; Ellis LM
    J Clin Oncol; 2003 Feb; 21(3):421-7. PubMed ID: 12560429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.